A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity
- 16 May 2007
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 25 (20), 4093-4102
- https://doi.org/10.1016/j.vaccine.2007.02.038
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Molecular characterization of a reassortant virus derived from Lassa and Mopeia virusesVirus Genes, 2006
- Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2Journal of Virology, 2006
- Historical Lassa Fever Reports and 30-year Clinical UpdateEmerging Infectious Diseases, 2006
- LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regenerationArchiv für die gesamte Virusforschung, 2004
- Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola VirusesJournal of Virology, 2001
- Characterization of arenaviruses using a family-specific primer set for RT-PCR amplification and RFLP analysis: Its potential use for detection of uncharacterized arenavirusesVirus Research, 1997
- Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene productsVirus Research, 1991
- Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccineVaccine, 1990
- Lassa FeverThe New England Journal of Medicine, 1986
- Ribonucleic acids of Machupo and Lassa virusesArchiv für die gesamte Virusforschung, 1984